Amneal Pharmaceuticals Claimed Company
Amneal Pharmaceuticals manufactures, markets and/or distributes more than 88 drugs in the United States. read more
HR or Marketing? Claim Your Free Employer Account
Amneal Pharmaceuticals VP of Investor Relations Salary
The average Amneal Pharmaceuticals VP of Investor Relations earns an estimated $127,013 annually. Amneal Pharmaceuticals' VP of Investor Relations compensation is $4,395 less than the US average for a VP of Investor Relations.
Last updated 23 days ago.
$77k
$120k
$129k
$225k
$127,013
Average Compensation
- $127,013
- avg. base
VP of Investor Relations Salaries at Amneal Pharmaceuticals
Compensation at Amneal Pharmaceuticals by Department
How VPs of Investor Relations at Amneal Pharmaceuticals Rate Their Compensation
The majority of VPs of Investor Relations at Amneal Pharmaceuticals believe they're compensated fairly. The vast majority (76%) of VPs of Investor Relations at Amneal Pharmaceuticals are satisfied with their benefits. See more compensation ratings at Amneal Pharmaceuticals
VP of Investor Relations Salaries at Similar Size Companies
×